产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 81928 | 6-Aminoindan-1-one | 69975-65-1 | 98% |  |
| Coming soon! | ||||
| 81805 | 4-Amino-Piperidine-1-Carboxylic Acid Benzyl Ester | 120278-07-1 |  | |
| Coming soon! | ||||
| 81720 | 2-Amino-5-chloro-3-methylbenzoic acid | 20776-67-4 | 98% |  |
| Coming soon! | ||||
| 81707 | 2-Aminomethyl-1-Boc-piperidine | 370069-31-1 | 98% |  |
| Coming soon! | ||||
| 81304 | 2-Amino-4'-fluorobenzophenone | 3800-06-4 | 98% |  |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81012 | 4-Acetoxy-3-bromobenzoic acid | 72415-57-7 | 97% |  |
| Coming soon! | ||||
| 80702 | AC710 | 1351522-04-7 | 97% |  |
| AC710 is a potent, selective PDGFR-family kinases inhibitor with Kd values of 0.6 nM/ | ||||
| 80311 | 4-Amino-3-iodobenzoic acid | 2122-63-6 | 97% |  |
| Coming soon! | ||||
| 80302 | ALPHA-BENZYL-4,6-O-BENZYLIDENE-MURAMIC ACID | 19229-57-3 | 97% |  |
| Coming soon | ||||
| 71804 | AZD2014(Vistusertib) | 1009298-59-2 | 98% by HPLC |  |
| AZD2014is a potent (IC50 2.81 nM), selective (inactive against 220 other kinases) inh | ||||
| 71802 | AZD9496 | 1639042-08-2 | 98% |  |
| 1) Sponsor:AstraZeneca2) Phase:Phase 13)AZD9496 is a novel, oral selective oestrogen | ||||
| 62504 | Alpelisib(BYL719) | 1217486-61-7 | >98% by HPLC | -cas-1217486-61-7.png) |
| NVP-BYL719 is novel and specific PI3K inhibitor.NVP-BYL719 has displayed promising re | ||||
| 62503 | Apitolisib(GDC-0980,RG7422) | 1032754-93-0 | >98% by HPLC | -cas-1032754-93-0.png) |
| Apitolisib(GDC-0980,RG7422) is a dual PI3K/mTOR inhibitor.GDC-0980 was potent across | ||||
| 61005 | Atazanavir | 198904-31-3 | 98% |  |
| Atazanavir(BMS-232632) is an highly potent HIV-1 protease inhibitor. | ||||
| 60702 | Abexinostat | 783355-60-2 | 96% |  |
| Abexinostat is a novel hydroxamate-based HDACi that showed broad spectrum anticancer | ||||
| 52771 | Axitinib | 319460-85-0 | 98% |  |
| Axitinib, also known as AG013736, is an orally bioavailable tyrosine kinase inhibitor | ||||
| 52770 | AVL-292 | 1202757-89-8 | 98% |  |
| AVL-292 is a covalent, highly selective, orally active small molecule inhibitor of Bt | ||||
| 52769 | AT9283 | 896466-04-9 | 98% |  |
| AT9283 is a small molecule a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and a | ||||
| 52768 | AT13387 | 912999-49-6 | 98% |  |
| AT13387 is a selective potent Hsp90 inhibitor with IC50 of 18 nM in A375 cells, displ | ||||
| 52767 | Asenapine maleate | 85650-56-2 | 98% |  |
| Asenapine maleate(Org 5222 maleate) inhibits adrenergic receptor (1, 2A, 2B, 2C) with | ||||
| 52766 | AP26113 | 1197958-12-5 | 98% | |
| AP26113 is a potent and selective active inhibitor of anaplastic lymphoma kinase(ALK) | ||||
| 52765 | AM095 free acid | 1228690-36-5 | 98% |  |
| AM095 is a potent LPA1 receptor antagonist with IC50 values of 0.98 and 0.73 M for re | ||||
| 52759 | APY0201 | 1232221-74-7 | 98% | |
| APY0201 is a potent, highly selective, ATP-competitive PIKfyve inhibitor (IC50=5.2 nM | ||||
| 52757 | AI-10-49 | 1256094-72-0 | 98% | |
| AI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBF-SMM | ||||
| 52750 | AEE788 | 497839-62-0 | 98% |  |
| AEE788(NVP-AEE 788) is a potent inhibitor of EGFR and HER2/ErbB2 with IC50 of 2 nM an | ||||
| 52741 | Alogliptin Benzoate | 850649-62-6 | 98% |  |
| Alogliptin benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of & | ||||
| 52739 | AHAS inhibitor | 219793-45-0 | 98% | |
| AHAS inhibitor is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug | ||||
| 52734 | AZ20 | 1233339-22-4 | 98% | |
| AZ20 is a potent and selective inhibitor of ATR with an IC50 of 5 nM; 8-fold selectiv | ||||
| 52719 | Afatinib | 850140-72-6 | 98% |  |
| Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), | ||||
| 52702 | AICAR | 2627-69-2 | 98% |  |
| AICAR (Acadesine), is an AMP-activated protein kinase activator, which is used for th | ||||